InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Symetryx Corp. Officer active across 1 company, notably NeuBase Therapeutics, Inc.. Aggregated, 3 filings have been published. Split: 1 buy · 2 sells. Total volume traded: €356k. Activity tracked since 1 September 2023. The latest transaction was filed on 14 September 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations